AI harnessed for early identification of cardiovascular problems
Cardiovascular disease is the world’s biggest killer, responsible for almost 18m deaths a year, according to the World Health Organization. But what if your likelihood of suffering from heart disease could be identified a decade in advance, enabling you to take preventive measures?
That is the promise of new medical imaging developed at the University of Oxford that received EU approval in 2021 and has begun to be used at several hospitals in the UK. The technology, CaRi-Heart, detects normally invisible signs of inflammation around coronary arteries from routine heart scans and uses artificial intelligence to identify the problems that could cause a heart attack.
You can read the full article via the Financial Times.
Read more
March 2024
Heart & Lung Health selects Caristo Diagnostics AI technology to provide early diagnosis of coronary artery disease UK-wide
UK-wide radiologist network to deploy Caristo’s pioneering CaRi-Heart® solution Oxford, March 19, 2024— Heart & Lung Health (HLH), a UK-wide network of…
Read more
March 2024
Caristo’s CaRi-Heart® technology addresses the gender gap in understanding cardiovascular disease risk in women
Cardiovascular risk prediction models based on traditional risk factors underestimate risk in women – review article by European Atherosclerosis Society…